AI is rapidly redefining how pharmaceutical companies plan, execute, and optimise drug launches. This exclusive insight brief explores the growing impact of AI (particularly Generative AI) across every stage of the launch lifecycle.
From early discovery to post-launch performance, AI is enabling faster timelines, smarter resource allocation, and more personalised engagement strategies.
Access the Insight Brief now >>